Veracyte
Genomic diagnostics company providing precision medicine solutions through advanced genomic testing for cancer and other diseases. Publicly traded on NASDAQ (VCYT).
Notes
Veracyte is a genomic diagnostics company providing precision medicine solutions through advanced genomic testing. The company is publicly traded on NASDAQ under the ticker symbol VCYT and is headquartered in South San Francisco, California.
Veracyte develops and commercializes genomic tests that help physicians make more informed diagnostic and treatment decisions. The company's tests cover multiple disease areas including:
- Thyroid cancer
- Lung cancer
- Prostate cancer
- Breast cancer
- Idiopathic pulmonary fibrosis
The company's tests use machine learning and genomic analysis to provide actionable insights that can help avoid unnecessary surgeries and guide treatment selection.
Team
- Marc Stapley - Chief Executive Officer
- LinkedIn: linkedin.com/in/marcstapley
- Bonnie Anderson - Founder & Executive Chair
Additional Research Findings
- NASDAQ: VCYT (publicly traded)
- Portfolio company of Bessemer Venture Partners
- Genomic diagnostics for cancer and other diseases
- Machine learning-powered analysis
- South San Francisco, California headquarters
- Founded in 2008
- Multiple FDA-cleared tests
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Bessemer Venture Partners | San Francisco, USA / Boston, USA | generalist | seedseries-a+3 | 3 |